Discovery of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide, an agonist of the alpha7 nicotinic acetylcholine receptor, for the potential treatment of cognitive deficits in schizophrenia: synthesis and structure--activity relationship.

Autor: Wishka DG; Pfizer Global Research & Development, Eastern Point Road, Groton, Connecticut 06340, USA., Walker DP, Yates KM, Reitz SC, Jia S, Myers JK, Olson KL, Jacobsen EJ, Wolfe ML, Groppi VE, Hanchar AJ, Thornburgh BA, Cortes-Burgos LA, Wong EH, Staton BA, Raub TJ, Higdon NR, Wall TM, Hurst RS, Walters RR, Hoffmann WE, Hajos M, Franklin S, Carey G, Gold LH, Cook KK, Sands SB, Zhao SX, Soglia JR, Kalgutkar AS, Arneric SP, Rogers BN

Publikováno v: Journal of medicinal chemistry [J Med Chem] 2006 Jul 13; Vol. 49 (14), pp. 4425-36.

Comparison of prostacyclin and prostaglandin E2 on gastric secretion, gastrin release, and mucosal blood flow in dogs.

Autor: Konturek SJ, Robert A, Hanchar AJ, Nezamis JE

Publikováno v: Digestive diseases and sciences [Dig Dis Sci] 1980 Sep; Vol. 25 (9), pp. 673-9.

Enteropooling assay: a test for diarrhea produced by prostaglandins.

Autor: Robert A, Nezamis JE, Lancaster C, Hanchar AJ, Klepper MS

Publikováno v: Prostaglandins [Prostaglandins] 1976 May; Vol. 11 (5), pp. 809-28.